Le Lézard
Classified in: Health, Business
Subjects: CON, PDT, OTC

North American Cannabis Holdings and Puration Announce Canadian Plan to Become McDonald's of Dispensaries and Sun Maid Raison of Growers


DALLAS, December 19, 2017 /PRNewswire/ --

North American Cannabis Holdings, Inc. (USOTC: USMJ) with Puration, Inc. (USOTC:PURA) today released an online presentation providing an update on the two companies coordinated efforts to be prepared for operations in Canada in conjunction with Canada's upcoming nationwide recreational marijuana legalization. North American Cannabis Holdings is in ongoing acquisition negotiations that include a role where Puration would provide its extraction expertise. Puration has separately announced introducing Cannabis infused beverages in Canada. The presentation is available online at aciconglomerated.com and the presentation narrative is available in its entirety below:

Canadian Nationwide Legalization Provides Platform For Cannabis Brand Strategy 

Shaken, not stirred. Everybody knows that's how James Bond takes his Martini's and who's cooler than James Bond? In spite of all health warnings, countless Hollywood productions still make cigarette smoking sexy. Alcohol and Tobacco have a brand identity independent of any specific corporate logo that drives the entire industry forward. In spite of all the statistical health risks associated with both, western culture has a certain romantic attraction to cigarette smoking alcoholics.  In summary, while balanced by health risk awareness, alcohol and tobacco enjoy a positive brand image that is well embedded into western culture.

Marijuana smoking has Cheech and Chong, Pineapple Express, and Jeff Sessions. Clearly, with revenues that arguably exceeds NFL ticket sales, marijuana has a following that does not likely reflect the goofy image portrayed by Hollywood, nor identify with Jeff Sessions ideas on what constitutes criminal behavior.

Without belaboring the brand identities of marijuana compared to alcohol and tobacco, let alone arguing the merits of legality for one versus the other, the point here is that no startup or early stage cannabis company can access the budget necessary to surmount the legacy of judgmental attitudes or goofy associations surrounding marijuana when the use or marijuana remains illegal. The alcohol and tobacco industry have spent decades and billions overcoming the stigma of prohibition and class action law suits to achieve the downright sex appeal they enjoy today. The investment capital necessary to transition from judged and goofy to sexy and alluring will not be forthcoming until marijuana prohibition is repealed nationwide. Hence, or attraction to Canada.

McDonald's of Dispensaries; Sun Maid Raisons of Growers; Splenda of Extracts 

So our big picture strategy in Canada is to take advantage of nationwide legalization as an overall environment were building a brand is possible.  Our even bigger picture strategy is take the brand to the United States once nationwide legalization is finally achieved.  The steps to achieving that strategy are first to get into the dispensary and growing business in Canada using a merger and acquisition strategy.  The second step will be to build a repeatable consumer focused dispensary and growing operation. The third step will be to repeat the repeatable consumer focused dispensary and growing operation by opening additional dispensary and growing operations.

We are in negotiations now with more than one party. We expect to narrow the field rapidly and commit to the best option. The negotiations are between North American Cannabis Holdings and the target Canadian businesses. The negotiations include Puration becoming an exclusive extractor for the Canadian operation. Being an exclusive extractor would additionally support Puration in its independent strategy as a cannabis infused beverage producer.

Obviously, this is only an outline of the strategy and the broad steps to achieve the strategy. The goal is to become the McDonald's of dispensaries, the Sun Maid Raisons of growers and the Splenda of extracts for infusion. Look for additional information to come with more detail on each of the steps in our overall strategy as our plan progresses and unfolds.

Learn more about USMJ, its parent company, ACI, and ACI's other holdings to include PURA by visiting: http://www.aciconglomerated.com/

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

ACI, USMJ and PURA contact info:
Steven Rash
[email protected]

+1-800-861-1350
https://www.aciconglomerated.com/contact/

SOURCE North American Cannabis Holdings, Inc. & Puration, Inc.


These press releases may also interest you

at 01:27
GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business...

at 01:05
Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic dermatitis in Australia, Singapore, Switzerland, and...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong first quarter performance, with net sales [1] of USD 2.5 billion, up 6% in constant currencies (up 5% in USD)Biosimilar business growing 21%...

at 01:00
dsm-firmenich today announces that, as part of its share repurchase program to cover share plans as announced on April 8, 2024, during the period from April 29, 2024 up to and including May 3, 2024 a total number of 547,165 shares have been...

at 00:45
Q1 2024 Results Further strong market share gains, disciplined execution Revenues flat yoy, outperforming markets; Adecco's relative revenue growth +600 bpsBy GBU, Adecco, +1% yoy, of which APAC +14%, Southern Europe & EEMENA +8%, DACH +7%; LHH -5%,...



News published on and distributed by: